Skip to main content

Table 1 Systemic parameters in the four intervention groups

From: Moderate intensity physical activity prevents increased blood glucose concentrations, fat pad deposition and cardiac action potential prolongation following diet-induced obesity in a juvenile-adolescent rat model

 

CON

PA

HFHC

HFHC + PA

Body weight (g)

444.8 ± 7.6

465.5 ± 8.9

441.1 ± 9.0

422.9 ± 8.0†

Retroperitoneal (g)

7.8 ± 1.1

7.9 ± 0.6

12.6 ± 1.2*†

9.0 ± 0.7

Subcutaneous (g)

8.3 ± 1.0

8.5 ± 0.7

10.1 ± 0.6

8.9 ± 1.3

Epididymal (g)

8.5 ± 1.0

6.2 ± 0.3

7.6 ± 0.7

7.8 ± 0.5

Mesenteric (g)

7.6 ± 0.9

8.5 ± 0.7

8.2 ± 0.5

7.4 ± 0.4

LV and septum (mg/g of bw)

2.2 ± 0.08

2.0 ± 0.08

2.1 ± 0.06

2.2 ± 0.08

RV (mg/g of bw)

0.5 ± 0.05

0.4 ± 0.03

0.5 ± 0.05

0.5 ± 0.02

Liver (mg/g of bw)

36.9 ± 0.7

36.8 ± 0.6

36.6 ± 0.9

37.5 ± 3.0

Spleen (mg/g of bw)

2.8 ± 0.1

2.7 ± 0.1

2.7 ± 0.1

2.9 ± 0.1

Kidneys (mg/g of bw)

7.6 ± 0.2

7.1 ± 0.1

8.2 ± 0.2*†

8.5 ± 0.2*†

4-HNE (mmol/L)

0.4 ± 0.2

10.4 ± 0.9*‡

3.6 ± 0.8*§

12.2 ± 1.7*‡

IL-6 (pg/mL)

770.0 ± 91.9

194.3 ± 31.5*‡

620.0 ± 91.7

417.1 ± 35.6*

IL-1β (pg/mL)

105.4 ± 13.6

49.4 ± 8.8*

67.2 ± 12.0

52.9 ± 3.9*

Nitrate/Nitrite (μmol/L)

22.6 ± 1.2

33.6 ± 2.7

68.8 ± 5.2*†§

34.5 ± 8.5

Glucose (mmol/L)

12.0 ± 1.1

11.9 ± 1.0

15.1 ± 0.6*†

12.4 ± 1.0

  1. Data expressed as Mean ± SEM; n = 16 for all groups. CON, control; PA, physical activity treated; HFHC, high-fat, high-carbohydrate fed; HFHC + PA, high-fat, high-carbohydrate fed and physical activity treated. *P < 0.05 vs CON, †P < 0.05 vs PA, ‡P < 0.05 vs HFHC, §P < 0.05 vs HFHC + PA.